Evaluation of high-throughput genomic assays for the Fc gamma receptor locus

PLoS ONE

Volumn 10, Issue 11, 2015, Pages

  Hargreaves, Chantal E ^a   Iriyama, Chisako ^a,b   Rose Zerilli, Matthew J J ^a   Nagelkerke, Sietse Q ^c   Hussain, Khiyam ^a   Ganderton, Rosalind ^d   Lee, Charlotte ^d   Machado, Lee R ^e,f   Hollox, Edward J ^e   Parker, Helen ^a   Latham, Kate V ^a   Kuijpers, Taco W ^c   Potter, Kathleen N ^a   Coupland, Sarah E ^g   Davies, Andrew ^a   Stackpole, Michael ^g   Oates, Melanie ^g   Pettitt, Andrew R ^g   Glennie, Martin J ^a   Cragg, Mark S ^a   Strefford, Jonathan C ^a   more..

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^e UNIVERSITY OF LEICESTER   (United Kingdom)

^f UNIVERSITY OF NORTHAMPTON   (United Kingdom)

^g UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; DNA; FCGR2A PROTEIN, HUMAN; FCGR2B PROTEIN, HUMAN; FCGR3A PROTEIN, HUMAN; MONOCLONAL ANTIBODY;

ARTICLE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; COPY NUMBER VARIATION; DNA DETERMINATION; EVALUATION STUDY; FCYR GENE; FEMALE; GENE LOCUS; GENE SEQUENCE; GENOME ANALYSIS; GENOTYPE; HUMAN; HUMAN CELL; INVESTIGATIVE PROCEDURES; MAJOR CLINICAL STUDY; MALE; MEASUREMENT ACCURACY; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; SANGER SEQUENCING; SINGLE NUCLEOTIDE POLYMORPHISM; TAQMAN ASSAY; DNA SEQUENCE; GENETICS; HIGH THROUGHPUT SEQUENCING; IMMUNOLOGY; ISOLATION AND PURIFICATION; MONONUCLEAR CELL; MULTIPLEX POLYMERASE CHAIN REACTION; PROCEDURES; VALIDATION STUDY;

ANTIBODIES, MONOCLONAL; DNA; DNA COPY NUMBER VARIATIONS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; LEUKOCYTES, MONONUCLEAR; MULTIPLEX POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, IGG; SEQUENCE ANALYSIS, DNA;

EID: 84952685380     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0142379     Document Type: Article

References (28)

1. Nimmerjahn F, Ravetch JV. FcgammaRs in health and disease. Curr Top Microbiol Immunol. 2011; 350:105-25. doi: 10.1007/82-2010-86 PMID: 20680807.
2. Breunis WB, van Mirre E, Geissler J, Laddach N, Wolbink G, van der Schoot E, et al. Copy number variation at the FCGR locus includes FCGR3A, FCGR2C and FCGR3B but not FCGR2A and FCGR2B. Human mutation. 2009; 30(5):E640-50. doi: 10.1002/humu.20997 PMID: 19309690.
3. Niederer HA, Clatworthy MR, Willcocks LC, Smith KG. FcgammaRIIB, FcgammaRIIIB, and systemic lupus erythematosus. Annals of the New York Academy of Sciences. 2010; 1183:69-88. doi: 10.1111/j.1749-6632.2009.05132.x PMID: 20146709.
4. Niederer HA, Willcocks LC, Rayner TF, Yang W, Lau YL, Williams TN, et al. Copy number, linkage disequilibrium and disease association in the FCGR locus. Human molecular genetics. 2010; 19 (16):3282-94. doi: 10.1093/hmg/ddq216 PMID: 20508037; PubMed Central PMCID: PMC2908468.
5. Chen J-Y, Wang C-M, Chang S-W, Cheng C-H, Wu Y-JJ, Lin J-C, et al. Association of FCGR3A and FCGR3B Copy Number Variations With Systemic Lupus Erythematosus and Rheumatoid Arthritis in Taiwanese Patients. Arthritis & Rheumatology. 2014; 66(11):3113-21. doi: 10.1002/art.38813 PMID: 25154742
6. Hargreaves CE, Rose-Zerill M.J.J., Machado L.R., Iriyama C., Hollox E.J., Cragg M.S., Strefford J.C. Fcγ receptors: genetic variation, function and disease. Immunological Reviews. 2015; 268(1):In press.
7. Cartron G, Dacheux L, Salles G, Solal-Celigny P, Bardos P, Colombat P, et al. Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene. Blood. 2002; 99(3):754-8. PMID: 11806974.
8. Weng WK, Levy R. Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2003; 21(21):3940-7. doi: 10.1200/JCO.2003.05.013 PMID: 12975461.
9. Bibeau F, Lopez-Crapez E, Di Fiore F, Thezenas S, Ychou M, Blanchard F, et al. Impact of Fc{gamma} RIIa-Fc{gamma}RIIIa polymorphisms and KRAS mutations on the clinical outcome of patients with metastatic colorectal cancer treated with cetuximab plus irinotecan. Journal of Clinical Oncology. 2009; 27 (7):1122-9. doi: 10.1200/JCO.2008.18.0463 PMID: 19164213.
10. Tamura K, Shimizu C, Hojo T, Akashi-Tanaka S, Kinoshita T, Yonemori K, et al. FcγR2A and 3A polymorphisms predict clinical outcome of trastuzumab in both neoadjuvant and metastatic settings in patients with HER2-positive breast cancer. Ann Oncol. 2011; 22(6):1302-7. doi: 10.1093/annonc/mdq585 PMID: 21109570.
11. Clynes RA, Towers TL, Presta LG, Ravetch JV. Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets. Nature medicine. 2000; 6(4):443-6. doi: 10.1038/74704 PMID: 10742152.
12. Glennie MJ, French RR, Cragg MS, Taylor RP. Mechanisms of killing by anti-CD20 monoclonal antibodies. Molecular immunology. 2007; 44(16):3823-37. doi: 10.1016/j.molimm.2007.06.151 PMID: 17768100.
13. Iafrate AJ, Feuk L, Rivera MN, Listewnik ML, Donahoe PK, Qi Y, et al. Detection of large-scale variation in the human genome. Nature genetics. 2004; 36(9):949-51. doi: 10.1038/ng1416 PMID: 15286789.
14. Sebat J, Lakshmi B, Troge J, Alexander J, Young J, Lundin P, et al. Large-scale copy number polymorphism in the human genome. Science. 2004; 305(5683):525-8. doi: 10.1126/science.1098918 PMID: 15273396.
15. Lake SL, Kalirai H, Dopierala J, Damato BE, Coupland SE. Comparison of formalin-fixed and snap-frozen samples analyzed by multiplex ligation-dependent probe amplification for prognostic testing in uveal melanoma. Investigative ophthalmology & visual science. 2012; 53(6):2647-52. doi: 10.1167/iovs.12-9584 PMID: 22427594.
16. van Dongen JJ, Langerak AW, Bruggemann M, Evans PA, Hummel M, Lavender FL, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 2003; 17(12):2257-317. doi: 10.1038/sj.leu.2403202 PMID: 14671650.
17. Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic acids research. 2002; 30(12):e57. PMID: 12060695; PubMed Central PMCID: PMC117299.
18. Hollox EJ, Detering JC, Dehnugara T. An integrated approach for measuring copy number variation at the FCGR3 (CD16) locus. Human mutation. 2009; 30(3):477-84. doi: 10.1002/humu.20911 PMID: 19143032; PubMed Central PMCID: PMC3600569.
19. Machado LR, Bowdrey J, Ngaimisi E, Habtewold A, Minzi O, Makonnen E, et al. Copy number variation of Fc gamma receptor genes in HIV-infected and HIV-tuberculosis co-infected individuals in sub-Saharan Africa. PloS one. 2013; 8(11):e78165. doi: 10.1371/journal.pone.0078165 PMID: 24250791; PubMed Central PMCID: PMC3826734.
20. Machado LR, Hardwick RJ, Bowdrey J, Bogle H, Knowles TJ, Sironi M, et al. Evolutionary history of copy-number-variable locus for the low-affinity Fcgamma receptor: mutation rate, autoimmune disease, and the legacy of helminth infection. American journal of human genetics. 2012; 90(6):973-85. doi: 10.1016/j.ajhg.2012.04.018 PMID: 22608500; PubMed Central PMCID: PMC3370267.
21. van Mirre E, Breunis WB, Geissler J, Hack CE, de Boer M, Roos D, et al. Neutrophil responsiveness to IgG, as determined by fixed ratios of mRNA levels for activating and inhibitory FcgammaRII (CD32), is stable over time and unaffected by cytokines. Blood. 2006; 108(2):584-90. doi: 10.1182/blood-2005-12-4997 PMID: 16551965.
22. Breunis WB, van Mirre E, Bruin M, Geissler J, de Boer M, Peters M, et al. Copy number variation of the activating FCGR2C gene predisposes to idiopathic thrombocytopenic purpura. Blood. 2008; 111 (3):1029-38. doi: 10.1182/blood-2007-03-079913 PMID: 17827395.
23. Blank M, Stefanescu R, Masuda E, Marti F, King P, Redecha P, et al. Decreased transcription of the human FCGR2B gene mediated by the-343 G/C promoter polymorphism and association with systemic lupus erythematosus. Hum Genet. 2005; 117(2-3):220-7. doi: 10.1007/s00439-005-1302-3 PMID: 15895258
24. Floto RA, Clatworthy MR, Heilbronn KR, Rosner DR, MacAry PA, Rankin A, et al. Loss of function of a lupus-associated FcgammaRIIb polymorphism through exclusion from lipid rafts. Nature medicine. 2005; 11(10):1056-8. doi: 10.1038/nm1288 PMID: 16170323.
25. Li SS, Gilbert PB, Tomaras GD, Kijak G, Ferrari G, Thomas R, et al. FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial. The Journal of clinical investigation. 2014; 124(9):3879-90. doi: 10.1172/JCI75539 PMID: 25105367; PubMed Central PMCID: PMC4151214.
26. Kokkat TJ, Patel MS, McGarvey D, LiVolsi VA, Baloch ZW. Archived formalin-fixed paraffin-embedded (FFPE) blocks: A valuable underexploited resource for extraction of DNA, RNA, and protein. Biopreservation and biobanking. 2013; 11(2):101-6. doi: 10.1089/bio.2012.0052 PMID: 24845430; PubMed Central PMCID: PMC4077003.
27. van der Heijden J, Breunis WB, Geissler J, de Boer M, van den Berg TK, Kuijpers TW. Phenotypic variation in IgG receptors by nonclassical FCGR2C alleles. Journal of immunology. 2012; 188(3):1318-24. doi: 10.4049/jimmunol.1003945 PMID: 22198951.
28. Veal CD, Freeman PJ, Jacobs K, Lancaster O, Jamain S, Leboyer M, et al. A mechanistic basis for amplification differences between samples and between genome regions. BMC genomics. 2012; 13:455. doi: 10.1186/1471-2164-13-455 PMID: 22950736; PubMed Central PMCID: PMC3469336.